Group Support Services Win TOPRA Accolades

Technical services and regulatory affairs consulting group Diamond Pharma Services Ltd, received both the Futures and Support Award at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards, in recognition of the Company’s expert regulatory services in supporting Kite Pharma Inc’s successful development of its CAR-T cell immunotherapy product for lymphoma and leukaemia.
Established in 2010, the TOPRA Awards recognise the achievement of individuals, teams and organisations in the regulatory affairs community. The Futures Award acknowledges the role of regulatory scientists in realising the potential of cutting-edge technologies and the Support Award recognises the critical role supporting organisations play in the drug development process and lifecycle of a drug.

Maureen Graham, Managing Director, Regulatory, Diamond Pharma Services, said: “Diamond is dedicated to supporting innovative companies, such as Kite Pharma, in the development of life-changing products and to bring new therapies to commercialisation for the benefit of patients. To have won both the Futures and Support TOPRA Awards for our work on this project is an absolute honour. The awards recognise the strength of the Diamond Pharma Services team, and we are extremely proud of our work to address a world-wide unmet medical need.”

Earlier in Autumn 2018, the company was also named ‘Best Specialist CRO’ at the Oxford Bioscience Network (OBN) Awards.